CYCN News and Press, Cyclerion Therapeutics Inc. From 08/23/21

CAMBRIDGE, Mass., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced participation in the Annual Biomarkers for Alzheimer’s Dis...

Continuing to progress clinical development of CY6463, a first-in-class, CNS-penetrant soluble guanylate cyclase (sGC) stimulator for the treatment of neurological diseases associated with cognitive impairment Advancing CY3018, a differentiated, next-generation, CNS-penetra...

Socket Mobile SCKT +79% on Q2 earningsAlzamend Neuro ALZN +62% after data showing safety of Alzheimer’s therapy in mouse studyVeoneer VNE +55% on earningsAcorda Therapeutics ACOR+49% on INBRIJA distribution and supply dealNRx Pharmaceuticals (NRXP) +5...

Cyclerion Therapeutics (CYCN) added ~15.8% in after-hours on its announcement of an upcoming presentation on the clinical trial design of CY6463, its candidate for Alzheimer’s disease.At the Alzheimer’s Association International Conference 2021 ((AAIC)) to be...

CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, today announced that it will present clinical trial design for a Phase 2a study of ...

Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership Beacon Biosignals and Cyclerion to extend and expand partnership on data collection and analytics strategy to facilitate development of Cyclerion investigational therapeutics for neurological diseases as...

CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies. This collaboration is expected to identify disease-relevant biomarkers to refine pa...

360 DigiTech (QFIN) -21%.Vista Gold (VGZ) -18% after secures $13.5M capital raise.Newegg Commerce (NEGG) -17%.BSQUARE (BSQR) -16%.Virpax Pharmaceuticals (VRPX) -15%.Marin Software (MRIN) -15%.LexinFintech (LX) -14%.Blonder Tongue Laboratories (BDR) -14%.Exela Technologies (XELA...

After two candidate failures over the past two years, Cyclerion Therapeutics, Inc. is pinning its hopes on CNS therapy CY6463. The soluble guanylate cyclase modulator is currently undergoing mid-stage evaluation for one CNS indication and should enter a Phase 2 study for another in 20...

4 Reddit Penny Stocks For Your June Watchlist Finding penny stocks on Reddit has become a favored pastime for many investors. While it can be challenging, investing in penny stocks can also be a profitable endeavor. There are a few ways to ensure your best chance at seeing your port...